Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Katrin Wetzko, MD, Matthias Blechschmidt, MD, Kristina Hölig, MD, Kirsten Poppe-Thiede, MD, Susanne Ganepola, MD, Roman Fischbach, MD, Rainer Ordemann, MD, Michael Laniado, MD, Bernhard Schulte-Hubbert, MD, Markus Schuler, MD, Livia Cotta, MD, Dietrich Braumann, MD, Gerhard Ehninger, MD, Frank Kroschinsky, MD

Blood (2011) 118 (21): 4057.

https://doi.org/10.1182/blood.V118.21.4057.4057

Published: 2011

Journal Articles

Frequency and Relevance of CD10 + CD19 + Hematogones after Allogeneic Stem Cell Transplantation.

Axel Nogai, Eckhard Thiel, Thomas Burmeister, Susanne Ganepola, Rita Lippoldt, Igor W. Blau, PD, Olga O. Blau, MD, PhD, Carola Tietze-Bürger, Lutz Uharek, Stefan Schwartz

Blood (2008) 112 (11): 3280.

https://doi.org/10.1182/blood.V112.11.3280.3280

Published: 2008

Journal Articles

Human Cytomegalovirus: Degranulation Is a Prominent Feature of Functionally Impaired pp65- and IE-1-Specific T-Cells in Patients after Allogeneic Stem Cell Transplantation

Stephan Fuhrmann, Susanne Ganepola, Lutz Uharek, Eckhard Thiel, Wolf-Dieter Ludwig, Hans-Dieter Volk, Florian Kern

Blood (2008) 112 (11): 2572.

https://doi.org/10.1182/blood.V112.11.2572.2572

Published: 2008

Journal Articles

Alemtuzumab but Not ATG Decreases Natural Killer (NK) Cell Activity towards Tumor Targets in the Early Phase after Allogeneic Stem Cell Transplantation.

Olaf Penack, MD, Lars Fischer, MD, Andrea Stroux, Chiara Gentilini, MD, Axel Nogai, MD, Arne Muessig, MD, Susanne Ganepola, MD, Eckhard Thiel, MD, Lutz Uharek, MD

Blood (2006) 108 (11): 2869.

https://doi.org/10.1182/blood.V108.11.2869.2869

Published: 2006

Journal Articles

CMV-Seropositive Patients Allografted with a CMV-Seronegative Donor Show Delayed or Missing CMV-Specific T-Cell Immune Response and Are at Higher Risk for CMV-Viremia and CMV-Disease.

Susanne Ganepola, Chiara Gentilini, Urte Hilbers, Goetz Hartung, Thoralf Lange, Joerg Hofmann, Uwe G. Liebert, Markus Hammer, Elisabeth Engelmann, Dietger Niederwieser, Eckhard Thiel, Lutz Uharek

Blood (2005) 106 (11): 3249.

https://doi.org/10.1182/blood.V106.11.3249.3249

Published: 2005

Journal Articles

WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.

Chiara Gentilini, MD, Urte Hilbers, Susanne Ganepola, MD, Carmen Scheibenbogen, Katy Freyberg, Dietger W. Niederwieser, Eckhard Thiel, Lutz Uharek

Blood (2005) 106 (11): 598.

https://doi.org/10.1182/blood.V106.11.598.598

Published: 2005

NARROW

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Frequency and Relevance of CD10 + CD19 + Hematogones after Allogeneic Stem Cell Transplantation.

Human Cytomegalovirus: Degranulation Is a Prominent Feature of Functionally Impaired pp65- and IE-1-Specific T-Cells in Patients after Allogeneic Stem Cell Transplantation

Alemtuzumab but Not ATG Decreases Natural Killer (NK) Cell Activity towards Tumor Targets in the Early Phase after Allogeneic Stem Cell Transplantation.

CMV-Seropositive Patients Allografted with a CMV-Seronegative Donor Show Delayed or Missing CMV-Specific T-Cell Immune Response and Are at Higher Risk for CMV-Viremia and CMV-Disease.

WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Frequency and Relevance of CD10 + CD19 + Hematogones after Allogeneic Stem Cell Transplantation.

Human Cytomegalovirus: Degranulation Is a Prominent Feature of Functionally Impaired pp65- and IE-1-Specific T-Cells in Patients after Allogeneic Stem Cell Transplantation

Alemtuzumab but Not ATG Decreases Natural Killer (NK) Cell Activity towards Tumor Targets in the Early Phase after Allogeneic Stem Cell Transplantation.

CMV-Seropositive Patients Allografted with a CMV-Seronegative Donor Show Delayed or Missing CMV-Specific T-Cell Immune Response and Are at Higher Risk for CMV-Viremia and CMV-Disease.

WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only